Caribou Biosciences, Inc. (CRBU) › Shareholders' EquityCaribou Biosciences, Inc. (CRBU) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: $29.95M2019: $7.46M2020: -$23.44M2021: $387.82M2022: $300.87M2023: $368.40M2024: $252.95M2025: $122.17M$122.17M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$122.17M-51.7%2024$252.95M-31.3%2023$368.40M+22.4%2022$300.87M-22.4%2021$387.82M+1754.8%2020-$23.44M-414.0%2019$7.46M-75.1%2018$29.95M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share